BEXION PHARMACEUTICALS INC has a total of 17 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are PERIOC LTD, RES CANCER INSTITUTE OF AMERICA and MOONSHOT PHARMA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Brazil | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Takigiku Ray | 15 |
#2 | Wyse Joseph W | 9 |
#3 | Monson Ellen K | 9 |
#4 | Wei Xiaochen | 9 |
#5 | Qi Xiaoyang | 6 |
#6 | Olowokure Olugbenga | 6 |
#7 | Cruze Iii Charles A | 5 |
#8 | Cruze Iii | 4 |
#9 | Joseph W Wyse | 1 |
#10 | Ellen K Monson | 1 |
Publication | Filing date | Title |
---|---|---|
EP3768246A1 | Saposin c pharmaceutical compositions and methods of treating cancer | |
US2018169120A1 | Combination therapy including sapc-dops for the treatment of pancreatic cancer |